vecabrutinib

(3R,3′R,4′S)-1′-(6-Amino-5-fluor-4-pyrimidinyl)-3-{[3-chlor-5-(trifluormethyl)phenyl]amino}-2-oxo-1,3′-bipiperidin-4′-carboxamid

(3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-{[3-chloro-5-(trifluoromethyl)phenyl]amino}-2-oxo-1,3′-bipiperidine-4′-carboxamide

(3R,3′R,4′S)-1′-(6-Amino-5-fluoro-4-pyrimidinyl)-3-{[3-chloro-5-(trifluorométhyl)phényl]amino}-2-oxo-1,3′-bipipéridine-4′-carboxamide

(3R,3′R,4′S)-1′-(6-amino-5-fluoropyrimidin-4-yl)-3-{[3-chloro-5-(trifluoromethyl)phenyl]amino}-2-oxo-[1,3′-bipiperidine]-4′-carboxamide

1510829-06-7

[1,3′-Bipiperidine]-4′-carboxamide, 1′-(6-amino-5-fluoro-4-pyrimidinyl)-3-[[3-chloro-5-(trifluoromethyl)phenyl]amino]-2-oxo-, (3R,3′R,4′S)-

PQ7O0OB5GU

vecabrutinib

vecabrutinib

vécabrutinib

vecabrutinibum

векабрутиниб

فيكابروتينيب

(3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-[(3R)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxopiperidin-1-yl]piperidine-4-carboxamide

BTK_HUMAN

MFCD31692359

Tyrosine-protein kinase BTK

vécabrutinib

vecabrutinibum

векабрутиниб

فيكابروتينيب

维卡替尼